Unjha Formulations' Stock Reaches All-Time High, Outperforms Sector and Sensex

Unjha Formulations, a microcap pharmaceutical company, saw its stock price reach an all-time high on November 9th, 2024. The stock has been given a 'Hold' rating by MarketsMOJO, a leading financial analysis platform.

The company's stock hit a new 52-week high of Rs.39 on the day, but underperformed the sector by -9.82%. After two consecutive days of gains, the stock saw a reversal in trend and opened with a 2% gain. It reached an intraday high of Rs.39 (5.41%) and a low of Rs.33.3 (-10%). The stock has been highly volatile today, with an intraday volatility of 7.88% calculated from the weighted average price.

Unjha Formulations is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. In the past year, the company's stock has outperformed the Sensex by 92.15%, while the Sensex has seen a growth of 22.33%.

This news highlights the strong performance of Unjha Formulations in the pharmaceutical industry and its positive outlook in the market. Investors should keep an eye on the company's future developments and performance.